Los Angeles Capital Management’s Gossamer Bio GOSS Stock Holding History

Los Angeles Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-131,216	Closed	-$43.1K	–	2396
2026 Q1	$43.1K	Buy	+131,216	New	+$206K	﹤0.01%	1524

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Los Angeles Capital Management's GOSS Position: Q2 2026 in Review

Los Angeles Capital Management sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 131,216 shares — an estimated $43.1K sold.

Los Angeles Capital Management first reported a position in GOSS in Q1 2026 and held it in 1 quarter. The position peaked at $43.1K in Q1 2026. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Los Angeles Capital Management reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
Los Angeles Capital Management sold 131,216 Gossamer Bio shares in Q2 2026, an estimated $43.1K.
Los Angeles Capital Management first reported a position in Gossamer Bio in Q1 2026 and held it in 1 quarter.
Los Angeles Capital Management's Gossamer Bio position peaked at $43.1K in Q1 2026.
170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.